Influence
October 27, 2021

Regenstrief research scientist co-authors national editorial to improve dementia care

Regenstrief research scientist co-authors national editorial to improve dementia care

Christopher M. Callahan, M.D., a Regenstrief Institute research scientist, co-authored an editorial in the Journal of the American Geriatrics Society (JAGS), “Improving care for dementia: Re-imagining the advocacy playbook,” that observes dementia care focused at the community, policy, and societal levels urgently requires more attention from researchers and clinicians.

According to the Geriatrics Healthcare Professionals website, JAGS has remained one of the oldest and most impactful journals dedicated exclusively to gerontology and geriatrics.

To accomplish the next step in what promises to be a long journey toward better dementia care, Dr. Callahan and his coauthor, Robyn Stone, DrPH, of LeadingAge, call for broadening the existing coalition supporting individuals with dementia. They encourage employing an advocacy model resembling the Americans with Disabilities Act, implemented in 1990. Future studies, they write, need to assess the extent to which this type of multi-stakeholder advocacy effort would ultimately affect health and quality of life outcomes for persons living with dementia and their care partners.

Dr. Callahan, who founded the Indiana University Center for Aging Research at Regenstrief Institute in 1997 and served as its director until 2018, is an internationally respected researcher-clinician. He has developed, tested and implemented new models of care designed to improve the health of older adults. These models facilitate collaboration among patients, their families, healthcare providers and community service agencies with an emphasis on applying health information technology. Both his research and clinical work focus on improving care for individuals with late-life depression and dementia.

Related News

image of pregnant woman with vaccine acting as protection from COVID virus

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two

Thomas Imperiale

Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., discusses the questions that will be investigated in

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental